Svetlana Gordeeva

Dr. Svetlana Gordeeva

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2025 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
EOEllina Grigorievna Oganesyan
Ellina Grigorievna Oganesyan
VKViktoriia Klimenteva
Viktoriia Klimenteva
IVIrina Vybornova
Irina Vybornova
VVValentina Venchakova
Valentina Venchakova
EPEkaterina Parshikova
Ekaterina Parshikova
ATAnastasia Taraskina
Anastasia Taraskina
Candida auris is an emerging multidrug-resistant fungal pathogen causing nosocomial transmission and invasive infections with high mortality. This study aimed to investigate the genetic relationships, enzymatic activities, and drug-resistance profiles of C. auris isolates to evaluate the population and epidemiological diversity of candidiasis in Russia. A total of 112 clinical isolates of C. auris were analyzed from May 2017 to March 2023 in 18 hospitals across Saint Petersburg, the Leningrad Region, and Moscow. Species identification was confirmed by ITS sequencing, and genotyping was performed using 12 short tandem repeat (STR) markers. Antifungal susceptibility was tested using Sensititre™ YeastOne™ plates, and hydrolytic enzyme production was measured by the plate method. ITS sequencing confirmed that all isolates belonged to a single ITS cluster (clades I and III). Fifteen distinct STR genotypes were identified, with genotype I being dominant (n = 53). The most variable of the analyzed markers turned out to be M3-Ia, which was represented in the Russian population by eight different variants. Fluconazole resistance was found in 111 isolates, 17% were resistant to amphotericin B, and 3.6% to 5-flucytosine. Phospholipase activity was strong in most strains, especially in urine isolates (p = 0.014). Conclusion: The predominance of STR genotype I and its variability at the M3-Ia locus suggest its association with nosocomial outbreaks and transmissibility in Russia.

10 September 2024 in Journal of microbiology, epidemiology and immunobiology
Verified
Journal Article
Open access
PDF file
GIGuzel Sh. Isaeva
Guzel Sh. Isaeva
ITIrina Tsvetkova
Irina Tsvetkova
ENEkaterina Nikitina
Ekaterina Nikitina
AZAlbina Z. Zaripova
Albina Z. Zaripova
LBLira T. Bayazitova
Lira T. Bayazitova
Sergey SidorenkoSergey Sidorenko
Sergey Sidorenko
Aim of the study. Genetic analysis of Streptococcus pneumoniae serogroups 15 and 11 circulating in Russia according to the following parameters: serotype affiliation; clonal complex (CC); presence of resistance and virulence determinants; relatedness to genetic lineages circulating in the world, and justification of inclusion of the actual serotypes of serogroups 15 and 11 in the future conjugate vaccine composition. Materials and methods. The study included whole genome data of S. pneumoniae serogroups 11 and 15. Results. Genomes of serogroup 15 strains from Russia are represented mainly by serotypes 15B and 15C, the majority of which belong to CC-1025 and CC-1262. CC-1025 is characterized by a more frequent association with invasive diseases. Representatives of CC-1025 and CC-1262 contain virulence determinants unique to these genetic lineages within the studied population of serogroup 15: oligopeptide transporters, fructose-specific PTS system, unique hydrolase variants, additional iron ion transporters, the gene of zinc metalloprotease ZmpC (activating human MMP9). The genomes of serogroup 11 are represented mainly by serotype 11A, the majority belong to CC-62 and CC-1012. The virulence determinants unique to CC-62 (within the studied serogroup 11) include bacteriocins, components of oligopeptide transport, flavin reductase-like protein (adhesin, also protects bacteria from oxidative stress), fucose processing operon, PsaA (adhesin, also a component of the ATP-binding cassette transporter that imports manganese ions). Conclusion. In the Russian Federation, serogroups 15 and 11 are the most common non-vaccine serogroups. No antimicrobial resistance determinants have been identified in the genomes of representatives of these serogroups. For each of the genetic lineages prevalent in Russia and associated with serogroups 15 and 11, unique virulence determinants within the studied serogroup have been identified, which may contribute to the success of these lineages. It is advisable to include serotypes 15B and 11A in vaccines promising for the Russian Federation.

1 January 2020 in Clinical Microbiology and Antimicrobial Chemotherapy
Verified
Journal Article
Open access
SGSvetlana Gordeeva
Svetlana Gordeeva
AZA.YU. Zolotarev
A.YU. Zolotarev
MMM.G. Movsisyan
M.G. Movsisyan
ARA.V. Rozinko
A.V. Rozinko
Objective. Assessment of bacterial identification effectiveness in clinical microbiology laboratory using the MALDI-MS based system BactoSCREEN. Materials and Methods. Bacteriological testing was done by the cultivation on Сolumbia agar with 5% of sheep blood (at 37°C for 24 hours). Colonies for identification were selected based on their growth pattern, type of hemolysis, morphology and consistency. The species identification was done by the MALDI-MS using the microbiology analyzer BactoSCREEN. Apart from MALDI-MS, we used morphology and biochemical methods for species identification when necessary. Serological tests were used for serovar and biovar identifications. Results. A total of 85945 bacterial identifications was performed in 2018. When compared to 2017, the throughput of the laboratory increased ten times. A total of 23252 isolates were obtained in the previously mentioned period. A single identification took 2.98–13.22 minutes including time for supporting procedures, whereas the staff time for one identification itself constituted an average of 1.55 minutes. When compared to manual methods, introduction of mass-spectrometry allowed us to achieve 3.5-fold decrease of the staff time in the average. Therefore, annual labor saving in terms of staffing corresponds to 11 full-time positions. Conclusions. In view of high throughput, analysis speed, simplicity and low cost of sample preparation, MALDI-MS identification fits well into the practice of clinical microbiology laboratory, especially when large-scale screening studies of bacterial cultures are required. The use of MALDI-MS is likely to be most promising when carrying out microbiological monitoring that is traditionally associated with large number of samples and wide range of microorganisms detected.

27 December 2024 in Journal Infectology
Verified
Journal Article
Open access
PDF file
DGD. A. Gusev
D. A. Gusev
VMV. B. Musatov
V. B. Musatov
EKE. V. Karnaukhov
E. V. Karnaukhov
KZK. V. Zhdanov
K. V. Zhdanov
SGSvetlana Gordeeva
Svetlana Gordeeva
APA. V. Pavlov
A. V. Pavlov
Goal. To investigate the spectrum of microorganisms, the level of antimicrobial resistance and to assess their effect on the outcomes of bacteremia among COVID­19 patients.Materials and methods. A retrospective analysis of potentially resistant bacteria detected in blood and the mortality rate among COVID­19 patients and patients with other diagnoses in the period from 01.01. – 12/31/2020.Results. In total, the analyzed pathogens were isolated from 168 patients, including 101 COVID­19 patients (group 1) and 67 patients with other diagnoses (group 2). Bloodstream infection were more often detected among COVID­19 patients (12.6 and 2.6 cases per 1000 patients, p<0.05). In group 1, the proportion of gram­-negative pathogens was higher than in group 2 (63.8% and 52.1%, p=0.012). The most commonly pathogen in group 1 is K. pneumoniae (31.5%, 41 cultures), in group 2 – S. aureus (35.2%, 25 cultures). Of particular importance is the identification of A. baumannii (32 and 4 cultures, p<0.001) and E. faecium (24 and 4 cultures, p=0.003) in group 1; S. aureus (25 and 11 cultures, p<0.001) and E. coli (9 and 6 cultures, p=0.038) – in group 2. Three leading types of microorganisms in group 1 have a high level of resistance: 96.9% of A. baumannii and 81.6% of K. pneumoniae were resistant to carbapenems, 36.8% of E. faecium was VRE. In group 1, several (22.8% and 6.0%, p=0.004) and resistant (70.3% and 41.8%, p<0.001) microorganisms were detected more frequently. The mortality rate of patients was higher in group 1 (68.3% and 50.7%, p=0.022). The occurrence of a bloodstream infection caused by a potentially resistant microorganism in COVID­19 patients is an unfavorable factor in the onset of death (p=0.022).Conclusion. COVID­19 patients with bacteremia have a high level of polymicrobial associations with a predominance of gram­-negative bacteria both in their composition and as a monoinfection. The isolated microorganisms have a high level of antimicrobial resistance, which must be taken into account when choosing antibiotics.

22 July 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
IPIvan Palagin
Ivan Palagin
Svetlana RachinaSvetlana Rachina
Svetlana Rachina
MSMarina Sukhorukova
Marina Sukhorukova
INIrina Nizhegorodtseva
Irina Nizhegorodtseva
UPUlyana Portnyagina
Ulyana Portnyagina
Roman KozlovRoman Kozlov
Roman Kozlov
Proper antibiotic usage education and training of medical students and healthcare professionals is the cornerstone to implement antimicrobial stewardship (AMS) programs worldwide. We conducted this voluntary and anonymous survey on current and preferred educational provision of AMS in Russia. Among 1358 polled respondents from six participating Centers located in geographically remote Federal Districts of Russia, the majority were nurses (52.8%) and doctors (42.0%). Results of the survey demonstrated better coverage of education in AMS on an undergraduate level (57.1%). More than half of respondents in total (52.4%) stated they had not received any postgraduate training. Those 38.4% respondents who received postgraduate teaching in AMS stated that it had been provided substantially by an employing hospital (28.4%) or by a medical university/college (22.3%). According to the conducted survey, the methods of education in AMS in Russian Federation mainly include traditional face-to-face lectures, presentations and provision with clinical guidelines, recommendations and printed materials. The involvement of e-learning and web-based online approaches was lacking. The survey allowed us the identify the key problems associated with training of healthcare workers in this field, in particular the varying availability of under- and postgraduate education in different parts of Russia.

1 January 2024 in Vestnik of Saint Petersburg University. Medicine
Verified
Journal Article
Closed access
PDF file
SUSt. Petersburg State University
St. Petersburg State University
VMVladimir Musatov
Vladimir Musatov
CBClinical Infectious Disease Hospital Named After S. P. Botkin
Clinical Infectious Disease Hospital Named After S. P. Botkin
AYAlexey Yakovlev
Alexey Yakovlev
CCCity Insurance Medical Company
City Insurance Medical Company
АЯАлексей Яковлев
Алексей Яковлев
Infectious diseases caused by resistant pathogens are a serious public health problem. Generalized forms of resistant infections involving the vascular system in the pathological process are often associated with the irrational use of antimicrobial drugs. The pandemic of a new coronavirus infection (COVID-19) was a significant factor that determined further negative trends in the development of antibiotic resistance. The aim of the study was to investigate the spectrum of microorganisms and analyze clinical and epidemiological data in patients with COVID-19 and bloodstream infections caused by resistant bacterial pathogens in the first 10 months of the pandemic. It has been shown that resistant gram-negative microorganisms are the leading etiological cause of bloodstream infections among hospitalized patients. A. baumannii, as a mono-etiological agent or as part of microbial associations, is the predominant causative pathogen of generalized infections in COVID-19 patients. A high level of comorbidity according to the Charlson index and previous courses of antibiotic therapy can be regarded as potential out-hospital predictors of contamination by resistant pathogens. The severe course of the COVID-19 including of the phenomenon of immunosuppression and the occurrence of sepsis determine the high level of hospital mortality. The addition of generalized infections is an extremely unfavorable factor that worsens the prognosis for recovery.